COMPANY
ClostraBio
Timeline
- Trial start Not phased (device or behavioral study): A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07336615 | A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals | Not phased (device or behavioral study) | Completed | Oct 9, 2025 | Jun 23, 2026 (actual) |